Prof Tan Puay Hoon
MBBS, FRCPA, FAMS, MD, FRCPath, MIAC
Chairman, Division of Pathology & Senior Consultant
Singapore General Hospital
Dr Tan Puay Hoon is Senior Consultant Histopathologist and Chairman, Division of Pathology, Singapore General Hospital, Singapore. She has active interests in breast, urologic and renal pathology, and was a Volume Editor of the 2012 WHO Classification of Tumours of the Breast. She sits on the Editorial Boards of Modern Pathology, Breast Cancer Research, Journal of Clinical Pathology, Pathology, Seminars in Diagnostic Pathology, and Analytical and Quantitative Cytology and Histology. She is Associate Editor of Histopathology and the Singapore Medical Journal. Apart from a busy service largely focused on subspecialty surgical signouts, she and her collaborators are recipients of several research grants related to translational studies of breast and prostate cancer. She is author of more than 400 publications, and participates regularly in regional and international meetings.
Dr Tan’s research interests in breast pathology centre around the classification of breast fibroepithelial lesions and their molecular pathogenesis, triple negative breast cancers, and ductal carcinoma in situ. In urologic pathology, she is engaged in prostate and renal cancer studies and is a contributor to the 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs.
She is the immediate Past-President of the International Society of Breast Pathology, and was Councillor for Asia of the International Society of Urological Pathology (2009 – 2015).
Prof Yun Wu
Department of Pathology,
Division of Pathology and Laboratory Medicine
MD Anderson Cancer Centre
Dr. Yun Wu is an American Board certified pathologist, sub-specializing in Breast Pathology at the University of Texas MD Anderson Cancer Center. She received her MD degree from Shanghai Medical University and her PhD degree in Molecular Pathology at the University of Texas MD Anderson Cancer Center, in 1991 and 1999, respectively. She completed her pathology residency at the University of Texas Southwestern Medical Center at Dallas and her Oncologic Pathology fellowship at Memorial Sloan Kettering Cancer Center in New York, NY. She has published more than 30 papers in reputed journals and serves on several editorial boards for pathology, oncology and cancer research journals. Her research interests are to identify potential biomarkers for breast cancer diagnosis and prognosis and to identify therapeutic targets for mechanism-based, individualized cancer therapy